In my opinion, MAA approval is crucial right now because, for any partnerships or new trials, the big question is where we’ll get the funding from. If we don’t receive the approval, who will trust NWBO enough to provide funding?
exactly I don't believe NWBO will be able to proceed on any of their many wild plans as described in their 10K or last 10Q without substantial non dilutive funding. If NWBO really plans doing so with a stock price sitting at 22 cents they are even more insane than I thought reverse split is not a magical cure to get tens if not hundred of millions of cash in.
Perhaps, Merck will extend a loan to NWBO for them to make an acquisition so NWBO can significantly raise their MC in order for Merck to buy ALL the rights and justify to their shareholders why they are paying 50B for NWBO and companies. Maybe, just maybe this is what it is going to take for Merck to capture the cancer market. Speculative yes...but also creative!